Results from the collaboration with Jansen was touted as recently as Nov presentation
and they were to be released by the end of Q3 2020....now , we will receive an update
by Q3 2020....?? Looks to me another delay is heading our way re Jansen collaboration
results...The results promised have had several delays in the past 13 months..
Also...how do you think the lodgement to FDA for the Pd (IA) in June 2020 line up with
our hopes of an early association with Jansen....Pd being an non invasive test , I would
speculate the FDA process would be quickly resolved ...unless the criteria for FDA approval
would include some form of association with Jansen drug and include the collabrative
results...
Agree with others ...futher patience required
any comments welcomed....cheers
Ann: Appendix 4C - December 2019 Quarterly Report, page-5
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
0.005(0.49%) |
Mkt cap ! $134.2M | |||
| Open | High | Low | Value | Volume |
| $1.03 | $1.06 | $1.00 | $134.2K | 131.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3987 | $1.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 4762 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |